Lot-document scope confirmed before quotation · Research use only
  • Specification Review
  • Lot Documents on Request
  • Business Support · Xi’an
  • Destination Eligibility Confirmed
西安诺和达生物科技有限公司
For research, development and manufacturing use only. Not for human or veterinary use.

Mitochondrial-derived peptide research · MOTS-c

MOTS-c (Human)

Product specifications & quotation

MOTS-c is a short peptide associated with mitochondria, the structures that help cells manage energy. Researchers study its links to metabolic signaling, cellular stress and exercise. Intervention findings largely come from laboratory and animal work. Measuring natural MOTS-c levels after exercise in people is a different experiment from administering the peptide. Here you can read those findings, check catalog identity and choose a research variant without confusing published studies with batch-specific evidence.

Research use only Lot documents on request
MOTS-c (Human) research product family with 3 catalog variants
AI-generated packaging mockup for catalog navigation. It is not a photograph of an actual supplied lot; container, label and presentation may vary.

Product family

Compound overview

Shared values below are consolidated from the current catalog record. They are not independent verification or lot results; request the applicable product specification and ask which lot records are available before ordering.

Product identity

Product type
Peptide research compound
Catalog family
MOTS-c (Human)
Research category
Metabolic & Weight Loss
Evidence status
Source-reviewed literature module available below
Intended use
Research, development and manufacturing use only

Literature reference parameters

Compound class
Mitochondrial-derived 16-amino-acid peptideCompound-level research classification
Evidence status
Cell and animal evidence; no identified human drug exposure dataSource-reviewed through 2026-08-28
Primary evidence anchor
2015 discovery paper · PMID 25738459See linked references and study articles
Original discovery publication
16-amino-acid mitochondrial-derived peptideThe original Lee et al. Cell Metabolism paper is PMID 25738459. PMID 25738453 is a separate commentary.

Identity safeguard Reference identifiers above describe the literature compound record. Confirm the supplied form, formula, molecular weight, purity and storage conditions against the applicable product specification and any available lot records.

Mechanism of action

How MOTS-c (Human) is studied

A target-to-pathway view grounded in the linked research records.

Glucose use and insulin sensitivity

Insulin sensitivity means the liver and muscle cells respond well to insulin, helping clear glucose from the blood. The 2015 discovery study in mice found MOTS-c acts mainly on skeletal muscle, where it indirectly activates AMPK, a cellular energy sensor. In mice, this protected against insulin resistance from ageing and high-fat feeding. These are animal experiments. They do not show that using this catalog peptide improves insulin sensitivity in people. PMID 25738459.

Body-weight and metabolic research

The same mouse experiments reported protection against diet-induced obesity. This is a key reason MOTS-c draws metabolic research interest. The proposed route involves muscle energy sensing through AMPK, not a direct fat-burning drug action. Because the evidence comes from animals, it supports further laboratory study of metabolism, not a proven weight-loss effect from this catalog product in humans. PMID 25738459.

Exercise performance: mice and human observations

A 2021 study reported that MOTS-c improved physical performance in young, middle-aged and old mice, and late-life intermittent treatment increased capacity and healthspan. Separately, exercise raised natural MOTS-c in human muscle and circulation. The human part measured the body's own peptide response during exercise. It did not give MOTS-c to people to test a performance benefit. PMID 33473109.

Reported research findings

What published studies report about MOTS-c (Human)

Reported outcomes are paired with their experimental model and evidence boundary.

Mouse experiments

Glucose use and insulin sensitivity

Mouse experiments reported protection against diet- and age-associated insulin resistance. These experiments did not test treatment benefits in people.

Experimental metabolic findings; human treatment benefit has not been established by these studies.

Read the primary study
Mice and human exercise observations

Exercise performance: mice and human observations

A 2021 study reported improved physical performance in mice given MOTS-c. A separate part of the study measured natural MOTS-c levels around exercise in 10 young men. The human participants were studied during exercise, rather than given MOTS-c to test a treatment benefit. PMID 33473109.

Human observation and administration experiments answer different questions.

Read the primary study
FDA review

Human drug-exposure data not identified

FDA states it has not identified human exposure data for drug products containing MOTS-c.

The “Human” catalog qualifier denotes a sequence reference, not permission for human use.

Read the primary study
Translation boundary: findings are limited to the evidence level stated on each card. Experimental protocol quantities are research details, not usage instructions.

Catalog options

Variant specifications

Pack-level catalog data; lot-level controls remain document-specific.

Catalog no.MS10
Pack size10 mg × 10 vials
Specification & documents for MS10

Product specification

10 mg nominal per vial · 10 vials per pack. Confirm supplied form, mass basis and lot release specifications before ordering.

Lot documentation

Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.

Catalog no.MS20
Pack size20 mg × 10 vials
Specification & documents for MS20

Product specification

20 mg nominal per vial · 10 vials per pack. Confirm supplied form, mass basis and lot release specifications before ordering.

Lot documentation

Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.

Catalog no.MS40
Pack size40 mg × 10 vials
Specification & documents for MS40

Product specification

40 mg nominal per vial · 10 vials per pack. Confirm supplied form, mass basis and lot release specifications before ordering.

Lot documentation

Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.

Quality system

Quality documentation

A listed document is not proof of availability for this lot. Ask the team to confirm the current COA status and the scope of any other records before ordering.

Lot-specific Certificate of AnalysisAvailability and scope must be confirmed for the selected catalog variant and lot
COA availability unconfirmed Ask about availability
Product Specification SheetAvailability and scope must be confirmed for the selected catalog variant and lot
Confirm before ordering Request
Analytical Method SummaryAvailability and scope must be confirmed for the selected catalog variant and lot
Confirm before ordering Request

Analytical interpretation

Interpret the documents, not just the headline number.

Use the source-reviewed guide to separate chromatographic area purity, quantitative assay, LC-MS identity, composition and stability evidence before comparing variants or requesting a lot record.

Open the Quality & Documentation Hub

HPLC area ≠ assayA dominant peak does not establish target mass fraction.

Intact mass ≠ full sequenceIdentity strength depends on resolution and orthogonal evidence.

Counterions affect contentWater, salt form and solvents change the as-is composition.

Storage needs a data basisShipping practice is not the same as stability evidence.

Evidence map

Research context

Published studies and regulatory records, not customer testimonials or usage guidance.

Preclinical

The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis

Lee C, et al. Cell Metabolism. 2015. PMID 25738459.

View primary record
FDA record

FDA bulk-substance safety concerns

U.S. FDA current MOTS-c summary.

View primary record
Evidence boundary: each card states its evidence type. Human trials and regulatory records describe the studied or regulated intervention; preclinical records remain model-specific. None verifies the identity, quality, safety or efficacy of this catalog lot or provides usage instructions.

Literature basis

Curated references

Third-party publications selected for direct relevance.

  1. 01

    The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis

    Lee C, et al. Cell Metabolism. 2015. PMID 25738453.

    Preclinical
  2. 02

    Certain Bulk Drug Substances That May Present Significant Safety Risks

    U.S. FDA. Current compounding safety-information page.

Research FAQ

MOTS-c (Human) questions

Concise answers for researchers comparing identity, evidence and catalog variants.

What effects are studied for MOTS-c (Human)?

The clearest effects come from mouse studies: protection against diet- and age-related insulin resistance, reduced diet-induced obesity, and better physical capacity, including when treatment started late in life. In humans, only natural MOTS-c changes after exercise have been measured, in a small observational setting. That is different from giving the peptide as a treatment, so human benefit from this research compound is not established. PMIDs 25738459, 33473109.

How should the MOTS-c (Human) research findings be understood?

A 2021 study reported that MOTS-c improved physical performance in young, middle-aged and old mice, and late-life intermittent treatment increased capacity and healthspan. Separately, exercise raised natural MOTS-c in human muscle and circulation. The human part measured the body's own peptide response during exercise. It did not give MOTS-c to people to test a performance benefit. PMID 33473109.

What does “Human” mean in the MOTS-c name?

It identifies the reference sequence. It does not mean the material is donor-derived, tested in people or intended for human use.

Which MOTS-c sizes can I enquire about?

MS10 lists 10 mg per vial, MS20 lists 20 mg and MS40 lists 40 mg. Each pack contains 10 vials. Confirm availability, supplied form and lot specifications with your quote.

Are these products in stock?

A catalogue listing is not a stock confirmation. Tell us the vial size, number of packs and destination so we can confirm availability and quotation details.

Can I request a COA before ordering?

Ask which documents are available for the selected variant and lot. A COA, specification sheet or method summary is not guaranteed by this listing; availability and scope must be confirmed before ordering.

What should I include in a quote request?

Include the product name, catalogue code, vial size, number of packs, research purpose, destination and required documents. Mention any requirements for supplied form, purity or peptide content so they can be assessed separately.

Does the labelled vial mass mean peptide content?

The listed mg per vial is a nominal catalogue size. It does not establish measured peptide content or purity. Confirm what the mass refers to and which measurements are available for the selected lot.

How should the material be stored?

Request the storage conditions for the exact supplied form and selected variant. A temperature stated for another supplier or a clinical drug preparation is not a verified storage specification for NHD catalog material.

Are the original metabolic results human clinical evidence?

No. The foundational intervention results came from cell and mouse experiments. They do not establish treatment benefits in people.

Does “Human” in the catalog name mean it can be used in people?

No. The qualifier identifies the sequence reference. It does not describe approval or suitability for human administration. Confirm the sequence and supplied form needed for the laboratory project.

What should I include in a research quotation request?

Send the exact product name, selected catalog variant, required quantity, destination and documents needed for the project. Specify whether the amount refers to powder mass or measured peptide content. Availability, price, lead time and document scope require confirmation.

Does a published study replace a lot-specific analytical report?

No. A paper describes the material and methods used in that study. It does not establish the identity, purity or content of a different supplied lot. Ask which records actually apply to the requested material; do not assume a COA is available.

Knowledge center

Related insights

Owned educational content connected to this family.

Knowledge tools

Continue with structured evidence

Move from this dossier into canonical evidence maps, verified status records, analytical interpretation and laboratory calculations.

Internal technical source review

Published-study results are tied to the linked records and kept separate from catalog-lot claims. Imported purity, storage and document-availability templates have been removed pending product- and lot-specific confirmation.

Editorial status: Source review complete · 2026-10-09 · Not independent medical review · Review policy

Technical procurement

Ready to request a quote?

Selected: MS10 · 10 mg × 10 vials